Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced dopaminergic neurotoxicity in inducible nitric oxide synthase- deficient mice

Synapse

Volumn 34, Issue 4, 1999, Pages 305-312

  Itzhak, Yossef ^a   Martin, Julio L ^a   Syed F, Ali ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Behavioral sensitization; Dopamine; INOS knockout mice; Locomotor activity; Striatum

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; METHAMPHETAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ENZYME DEFICIENCY; ENZYME INDUCTION; ENZYME POLYMORPHISM; HYPOTHERMIA; LOCOMOTION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0033573242     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2396(19991215)34:4<305::aid-syn6>3.0.co;2-%23     Document Type: Article

References (55)

1. Ali SF, Newport GD, Holson RR, Slikker W Jr, Bowyer JF. 1994. Low environmental temperature or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38.
2. Beckman JS, Beckman TW, Chen J, Marshall PM, Freeman BA. 1990. Apparent hydroxy radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1621-1624.
3. Bowyer JF, Tank AW, Newport GD, Slikker W Jr, Ali SF, Holson RR. 1992. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817-824.
4. Cadet JL, Brannock C. 1998. Free radicals and pathobiology of brain dopamine systems. Neurochem Int 32:117-131.
5. Cadet JL, Sheng P, Ali SF, Rothman R, Carlson E, Epstein CJ. 1994. Attenuation of methamphetamine -induced neurotoxicity in copper/ zinc superoxide dismutase transgenic mice. J Neurochem 62:380-383.
6. Callahan BT, Ricaurte GA. 1998. Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity. NeuroReport 9:2691-2695.
7. Chan P, Delanney LE, Irwin I, Langsten JW, Di Monte DA. 1991. Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropvridine in mouse brain. J Neurochem 57:348-351.
8. Chiueh CC, Krishna G, Tulsi P, Obata T, Lang K, Huang S-L, Murphy DL. 1992. Intracranial microdialysis of salicylic acid to detect hydroxy radical generation through dopamine autoxidation in the caudate nucleus: effect of MPP+. Free Radicals Biol Med 13:581-583.
9. Dawson V.L, Kizushi V.M, Huang PL, Snyder SH, Dawson TM. 1996. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci 16:2479-2487.
10. Desai V.G, Feuers RJ, Hart RW, Ali SF. 1996. MPP-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport. Brain Res 715:1-8.
11. De Vito MJ, Wagner GC. 1989. Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacol 28:1145-1150.
12. Di Monte DA, Royland JE, Jakowec MW, Langsten JW. 1996. Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem 67:2443-2450.
13. Fleckenstein AE, Metzger RR, Beyeler ML, Gibb JW, Hanson GR. 1997. Oxygen radicals diminish dopamine transporter function in rat striatum. Eur J Pharmacol 334:111-114.
14. Fornai F, Vaglini F, Maggio R, Bonuccelli U, Corsini GU. 1997. Species differences in the role of excitatory amino acids in experimental parkinsonism. Neurosci Biobehav Rev 21:401-415.
15. Fuller RW, Hemrick-Luecke S. 1980. Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science 209:305-307.
16. Gibb JW, Johnson M and Hanson GR. 1990. Neurochemical basis of neurotoxicity. Neurotoxicology 11:317-321.
17. Gibb JW, Kogan FJ. 1979. Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmieddebergs Arch Pharmacol 310:185-187.
18. Giovanni A, Liang LP, Hastings TG, Zigmond MJ. 1995. Estimating hydroxy radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 64:1819-1825.
19. Hanson GR, Gibb JW, Metzger RR, Kokoshka JM. and Fleckenstein AE. 1998. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequence? Ann NY Acad Sci 30:103-107.
20. Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT. and Beal MF. 1996. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med 2:1017-102.
21. Hasegawa E, Takeshige K, Oishi T, Murai Y, Minikami S 1990. 1-Methyl-4-phenyl-pyridinium (MPP+) induces NADH-dependent superoxide formation, and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170:1049-1055.
22. Heikkila RE, Hess A, Duvosin RC. 1984. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-12,3,6-tetrahydropyridine in mice. Science 224:1451-1453.
23. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, MacMicking JD, Nathan C, Kubes P. 1997. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 11:955-964.
24. Itzhak Y. 1997. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharmacol Exp Ther 282:521-527.
25. Itzhak Y, Ali SF. 1996. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67:1770-1773.
26. Itzhak Y, Gandia C, Huang PL, Ali SF. 1998a. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther 284:1040-1047.
27. Itzhak Y, Martin JL, Black MD. and Ali SF. 1998b. Effect of melatonin on methamphetamine- and MPTP-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization. Neuropharmacol 37:781-791.
28. Itzhak Y, Martin JL, Black, .M.D Ali SF, Huang PL. 1998c. Resistance of neuronal nitric oxide synthase-deficient mice to cocaine-induced locomotor sensitization. Psychopharmacol 140:378-386.
29. Itzhak Y, Martin JL, Black MD, Huang PL. 1998d. The role of neuronal nitric oxide synthase in cocaine-induced conditioned place preference NeuroReport 9:2485-2488.
30. Itzhak Y, Martin JL, Black MD, Ali, SF. 1999. Effect of the dopaminergic neurotoxin MPTP on cocaine-induced locomotor sensitization. Pharmacol Biochem Behav 63:101-107.
31. Kogan FJ, Nichols WK, Gibb JW. 1976. Influence of methamphetamine on nigra and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 36:363-371.
32. Kuperman DI, Freyladenhoven TF, Schmued L, Ali SF. 1997. Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat shock protein induction. Brain Res 771:221-227.
33. Langsten JW, Ballard P, Tetrud JW, Irwin 11983. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis, Science 219:979-980.
34. Lowry OH, Rosebrrough NJ, Farr AL, Randall RJ. 1951. Protein measurements with Folin phenol reagent. J Biol Chem 193:265-275.
35. MacMicking J, Xie QW, Nathan C. 1997. Nitric oxide and macrophage function. Ann Rev Immunol 15:323-350.
36. Malberg JE, Sabol KE, Seiden LS. 1996. Co-adminiatration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. J Pharmacol Exp Ther 278:258-267.
37. Malberg JE, Seiden LS. 1998. Small changes in ambient temperature causes large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18:5086-5094.
38. McCann UA, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. 1998. Reduced striatal dopamine transporter density in abstinent methamphetamme and methcathinon users: evidence from positron emission tomography studies with [C]WIN-35,428. J Neurosci 18:8417-8422.
39. Miller DB, O'Callagahan JP. 1994. Environmental-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752-760.
40. Nash JF, Yamamoto BK. 1992. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581:237-243.
41. Nicklas WJ, Vyas I, Heikkila RE. 1985. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36:2503-2508.
42. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson, TM. 1996. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93:4565-4571.
43. Schulman H. 1997. Nitric oxide: a spatial second messenger. Mol Psychiat 2:296-299.
44. Schulz JB, Matthews RT, Muqit MM.K, Browne SE, Beal MF. 1995. Inhibition of neuronal nitric oxide synthase protects against MPTP-induced neurotoxicity in mice. J Neurochem 64:936-939.
45. Seiden LS, Vosmer G. 1984. Formation of 6-hydroxydopamine in caudate nucleus of rat brain after a single large dose of methamphetamine. Pharmacol Biochem Behav 21:29-31.
46. Sheng P, Cerruit C, Ali SF, Cadet JL. 1996. Nitric oxide is a mediator of methamphetamine induced neurotoxicity: in vitro evidence from primary cultures of mesencephalic cells. Ann NY Acad Sci 801:174-186.
47. Snyder SH. 1992. Nitric Oxide: first in a new class of neurotransmitter? Science, 257:494-496.
48. Sonsalla PK, Nicklas WJ. 1992. MPTP and animal models of Parkinson's disease. In W.C. Koller, editor. Handbook of Parkinson's Disease 2nd ed. New York: Marcel Dekker; p 319-340.
49. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J. 1980. Long-lasting depletion of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151-160.
50. West AR, Galloway MP. 1997. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanism. Neuropharmacol 36: 1571-1581.
51. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk, G.A, Shannak K, Haycock JW, Kish SJ. 1996. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med 2:699-703.
52. Wolf MA. 1998. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
53. Yamamoto BK, Zhu W. 1998. The effect of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 287:107-114.
54. Yun H-Y, Dawson V.L, Dawson TM. 1997. Nitric oxide in health and disease of the nervous system. Mol Psychiatry 2:300-310.
55. Zhang J, Dawson V.L, Dawson TM, Snyder SH. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687-689.